查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1425510

2024 年糖组学或糖生物学全球市场报告

Glycomics or Glycobiology Global Market Report 2024
出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，糖组学或糖生物学的市场规模迅速扩大。将从2023年的15.9亿美元成长到2024年的18.4亿美元，复合年增长率为15.6%。过去的成长是由于人们对生物系统中聚醣的认识不断提高、聚醣相关资料库和资源的扩展、协作研究倡议的增加、聚醣合成和工程的进步以及聚醣生物标誌物的识别而推动的。

2023 年，北美是糖组学或糖生物学市场占有率最大的地区。预计亚太地区将成为预测期内成长最快的地区。糖组学或糖生物学市场报告涵盖的地区包括亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球糖组学或糖生物学市场驱动因素和限制
    • 市场驱动力
    • 市场限制
  • 2018-2023 年全球糖组学或糖生物学市场规模表现与成长
  • 全球糖组学或糖生物学市场规模和成长预测，2023-2028、2033

第六章市场区隔

  • 全球糖组学或糖生物学市场，按产品、性能和预测细分，2018-2023、2023-2028、2033
  • 酵素
  • 套件
  • 试剂和化学品
  • 装置
  • 碳水化合物
  • 全球糖组学或糖生物学市场，按应用、性能和预测细分，2018-2023、2023-2028、2033
  • 药物研发发现与开发
  • 疾病诊断
  • 其他用途
  • 全球糖组学或糖生物学市场，按最终用户细分、绩效和预测，2018-2023、2023-2028、2033
  • 学术研究所
  • 製药和生物技术公司
  • 临床实验室

第 7 章 区域与国家分析

  • 全球糖组学或糖生物学市场，按地区、表现和预测，2018-2023、2023-2028、2033
  • 全球糖组学或糖生物学市场，按国家、绩效和预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争形势及公司概况

  • 糖组学或糖生物学市场的竞争形势
  • 糖组学或糖生物学市场的公司简介
    • Water Corporation
    • Aligent Technologies Inc.
    • Bruker Corporation
    • Merck Co. &KgaA
    • New England Biolabs Inc.

第31章竞争基准化分析

第 32 章竞争对手仪表板

第三十三章 重大併购

第34章 未来前景与可能性分析

第35章附录

简介目录
Product Code: r12741

Glycomics or Glycobiology Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on glycomics or glycobiology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for glycomics or glycobiology? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The glycomics or glycobiology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Product: Enzymes; Kits; Reagents and Chemicals; Instruments; Carbohydrates
  • 2) By Application: Drug Discovery and Development; Disease Diagnostics; Other Applications
  • 3) By End-user: Academic Research Institutes; Pharmaceutical and Biotechnology Companies; Clinical Laboratories
  • Companies Mentioned: Water Corporation; Aligent Technologies Inc.; Bruker Corporation; Merck Co. & KgaA; New England Biolabs Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Glycomics or glycobiology encompasses the exploration of saccharides' structures, biosynthesis, and biological functions, delving into the intricate world of sugar chains or glycans widely present in natural systems. These glycans are thoroughly examined within the realm of glycobiology for their structural composition, production processes, and biological significance.

The primary products associated with glycomics or glycobiology include enzymes, kits, reagents and chemicals, instruments, and carbohydrates. Enzymes, as biological polymers, serve as catalysts for biochemical reactions. These products find application across various domains such as drug discovery and development, disease diagnostics, among others, and are extensively utilized within academic research institutes, pharmaceutical and biotechnology companies, as well as clinical laboratories.

The glycomics or glycobiology market research report is one of a series of new reports from The Business Research Company that provides glycomics or glycobiology market statistics, including glycomics or glycobiology industry global market size, regional shares, competitors with a glycomics or glycobiology market share, detailed glycomics or glycobiology market segments, market trends and opportunities, and any further data you may need to thrive in the glycomics or glycobiology industry. This glycomics or glycobiology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The glycomics or glycobiology market size has grown rapidly in recent years. It will grow from $1.59 billion in 2023 to $1.84 billion in 2024 at a compound annual growth rate (CAGR) of 15.6%. Historical growth can be attributed to the heightened awareness of glycans within biological systems, the expansion of glycan-related databases and resources, an increase in collaborative research initiatives, advancements in glycan synthesis and engineering techniques, and the identification of glycan biomarkers.

The glycomics or glycobiology market size is expected to see rapid growth in the next few years. It will grow to $3.38 billion in 2028 at a compound annual growth rate (CAGR) of 16.4%. The projected growth in the forecast period is driven by the advancement of glycan-focused artificial intelligence (AI) and data analytics, the expansion of glycobiology-based drug development, the integration of glycomics in disease biomarker discovery, and the utilization of personalized medicine and glycan-based therapeutics. Major trends expected during this period encompass cross-disciplinary collaborations between scientific fields, a deeper exploration of glycosylation patterns in disease mechanisms, the emergence of innovative precision medicine and personalized therapies utilizing glycobiology insights, advancements in glycoanalytical tools and technologies, and the utilization of glycans in the development of immunotherapy and vaccines.

The surge in demand for medications catering to severe chronic diseases is poised to drive the growth of the glycomics or glycobiology market. Chronic diseases, which persist over the long term without definitive cures, prompt extensive research into glycomics to understand glycosylation changes and their functional implications in drug development for these conditions. According to the American Cancer Society's Cancer Facts and Figures 2022-2024, the number of cancer survivors, considered a chronic disease, is projected to increase from 22.5 million in 2032 to an estimated 26 million by 2040. Hence, the escalating demand for medications to treat severe chronic diseases acts as a significant driver for the glycomics or glycobiology market.

The rising need for pharmaceutical products is expected to be a major driver for the growth of the glycomics or glycobiology market. These products encompass drugs specifically formulated to diagnose, prevent, treat, or cure various medical conditions. Glycomics and glycobiology play crucial roles in pharmaceutical development by elucidating disease mechanisms, identifying therapeutic targets, and optimizing drug design and effectiveness. According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), the total pharmaceutical production in Europe surged to $384,200 million (€340,000 million) in 2022, marking a significant 4.95% increase from the preceding year's $366,267 million (€323,950 million). Consequently, the heightened demand for pharmaceutical products acts as a catalyst propelling the glycomics or glycobiology market's growth.

A prevailing trend in the glycomics or glycobiology market is the emphasis on investments in research and development (R&D) endeavors. Prominent research institutions are channeling funding into glycobiology research centers, aiming to further advancements in glycomics or glycobiology. For instance, Griffith University's Institute for Glycomics unveiled the ACRF International center for Cancer Glycomics in August 2022. This pioneering facility, established with a $2.6 million ACRF grant, is dedicated to unraveling cancer glycocoding. It is envisioned as a unique resource, driving enhanced understanding of the glycocode and translating discoveries into clinical outcomes, ultimately improving the lives of cancer patients.

Leading companies within the glycomics or glycobiology market are innovating by developing cutting-edge products like glycan screening kits to cater to expanded customer bases and augment revenue streams. Glycan Screening Kits are specialized tools designed for comprehensive immunofluorescence detection of glycan expression in tissue sections, aiding researchers in characterizing complex glycans for insights into disease biomarkers and protein modifications. Vector Laboratories Inc., in July 2022, introduced its breakthrough product, the Glysite Scout Glycan Screening Kits. These fully integrated immunofluorescence kits offer robust capabilities for profiling glycan expression in tissue sections. The kits empower researchers to gain valuable insights into the significance of glycomics in samples, particularly in understanding post-translational protein modifications and disease biomarkers. With curated lectin selections, these kits enable the identification of major surface glycan motifs, enriching the understanding of disease progression, treatment impacts, and tissue characterization.

In January 2021, Neogen, a renowned US-based food safety company specializing in testing solutions for the food industry, completed the acquisition of Megazyme for an undisclosed sum. This strategic acquisition enabled Neogen to integrate Megazyme's product line into its portfolio, bolstering Neogen's position and enhancing its connections with key players in the food production and manufacturing sectors. Megazyme, headquartered in Ireland, is recognized for its expertise in developing and manufacturing analytical solutions, particularly in the realm of glycobiology enzyme products. Neogen's acquisition of Megazyme signifies a strategic move to expand its product offerings, leveraging Megazyme's specialized product line to further fortify Neogen's relationships with major food producers and corporations.

Major companies operating in the glycomics or glycobiology market report are Water Corporation, Aligent Technologies Inc., Bruker Corporation, Merck Co. & KgaA, New England Biolabs Inc., Danaher Corporation, Shimadzu Corporation, ProZyme Inc., Takara Bio Inc., S-BIO Pte. Ltd., Asparia Glycomics SL, Lectenz Bio, Chemily Glycoscience LLC, Z Biotech LLC, RayBiotech Inc., Thermo Fisher Scientific Inc., Promega Corporation, Bio-Techne Corp., Sumitomo Bakelite Co. Ltd., Bruker Corporation, AMS Bio LLC, Ludger Ltd., CD BioGlyco Ltd., GlycoDiag SAS, Kode Biotech Limited, Glyxera GmBH, Glycomix Ltd., IEC Group Ltd., and R&D Systems Inc.

North America was the largest region in the glycomics or glycobiology market share in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the glycomics or glycobiology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the glycomics or glycobiology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The glycomics or glycobiology market includes revenues earned by entities by maintaining tissue structure, porosity, and integrity. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Glycomics or Glycobiology Market Characteristics

3. Glycomics or Glycobiology Market Trends And Strategies

4. Glycomics or Glycobiology Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Glycomics or Glycobiology Market Size and Growth

  • 5.1. Global Glycomics or Glycobiology Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Glycomics or Glycobiology Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Glycomics or Glycobiology Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Glycomics or Glycobiology Market Segmentation

  • 6.1. Global Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Enzymes
  • Kits
  • Reagents and Chemicals
  • Instruments
  • Carbohydrates
  • 6.2. Global Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Drug Discovery and Development
  • Disease Diagnostics
  • Other Applications
  • 6.3. Global Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Academic Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Clinical Laboratories

7. Glycomics or Glycobiology Market Regional And Country Analysis

  • 7.1. Global Glycomics or Glycobiology Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Glycomics or Glycobiology Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Glycomics or Glycobiology Market

  • 8.1. Asia-Pacific Glycomics or Glycobiology Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Glycomics or Glycobiology Market

  • 9.1. China Glycomics or Glycobiology Market Overview
  • 9.2. China Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Glycomics or Glycobiology Market

  • 10.1. India Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Glycomics or Glycobiology Market

  • 11.1. Japan Glycomics or Glycobiology Market Overview
  • 11.2. Japan Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Glycomics or Glycobiology Market

  • 12.1. Australia Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Glycomics or Glycobiology Market

  • 13.1. Indonesia Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Glycomics or Glycobiology Market

  • 14.1. South Korea Glycomics or Glycobiology Market Overview
  • 14.2. South Korea Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Glycomics or Glycobiology Market

  • 15.1. Western Europe Glycomics or Glycobiology Market Overview
  • 15.2. Western Europe Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Glycomics or Glycobiology Market

  • 16.1. UK Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Glycomics or Glycobiology Market

  • 17.1. Germany Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Glycomics or Glycobiology Market

  • 18.1. France Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Glycomics or Glycobiology Market

  • 19.1. Italy Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Glycomics or Glycobiology Market

  • 20.1. Spain Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Glycomics or Glycobiology Market

  • 21.1. Eastern Europe Glycomics or Glycobiology Market Overview
  • 21.2. Eastern Europe Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Glycomics or Glycobiology Market

  • 22.1. Russia Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Glycomics or Glycobiology Market

  • 23.1. North America Glycomics or Glycobiology Market Overview
  • 23.2. North America Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Glycomics or Glycobiology Market

  • 24.1. USA Glycomics or Glycobiology Market Overview
  • 24.2. USA Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Glycomics or Glycobiology Market

  • 25.1. Canada Glycomics or Glycobiology Market Overview
  • 25.2. Canada Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Glycomics or Glycobiology Market

  • 26.1. South America Glycomics or Glycobiology Market Overview
  • 26.2. South America Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Glycomics or Glycobiology Market

  • 27.1. Brazil Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Glycomics or Glycobiology Market

  • 28.1. Middle East Glycomics or Glycobiology Market Overview
  • 28.2. Middle East Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Glycomics or Glycobiology Market

  • 29.1. Africa Glycomics or Glycobiology Market Overview
  • 29.2. Africa Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Glycomics or Glycobiology Market Competitive Landscape And Company Profiles

  • 30.1. Glycomics or Glycobiology Market Competitive Landscape
  • 30.2. Glycomics or Glycobiology Market Company Profiles
    • 30.2.1. Water Corporation
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Aligent Technologies Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Bruker Corporation
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Merck Co. & KgaA
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. New England Biolabs Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Glycomics or Glycobiology Market Competitive Benchmarking

32. Global Glycomics or Glycobiology Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Glycomics or Glycobiology Market

34. Glycomics or Glycobiology Market Future Outlook and Potential Analysis

  • 34.1 Glycomics or Glycobiology Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Glycomics or Glycobiology Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Glycomics or Glycobiology Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer